薛博仁1.pptVIP

下载本文档

18
0
约1.58万字
约 69页
2017-06-16 发布于江西
举报
版权申诉

薛博仁1.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

薛博仁1

不动杆菌感染治疗：如果碳青霉烯敏感，则首选碳青霉烯 * * 2003 至2010 年第1 季區域級以上醫院加護病房院內感染CRAB 比例之6 個主要區域別分佈如圖十四。加護病房CRAB 比例於2003 年以北區(29%)及台北區(24%)較為嚴重；於2003 年至2008 年期間，各區域CRAB 問題持續惡化，2010 年(統計至第1 季)CRAB 比例以南區(80%)及中區(77%)最高 Taking the focus to Asia-Pacific region. ESBL-producing bacteria are more common in China, Korea, and Thailand. In China, more than 40% of E. coli and more than 20% of Klebsiella and Enterobacter are ESBL-producers. In Korea, 44% of Klebsiella species produce ESBL. In Thailand, about 30% of three bacteria were ESBL-producers. In Taiwan, 9% of E. coli, 17% of Klebsiella spescies, and 25% of Enterobacter are ESBL-producers. Taking the focus to Asia-Pacific region. ESBL-producing bacteria are more common in China, Korea, and Thailand. In China, more than 40% of E. coli and more than 20% of Klebsiella and Enterobacter are ESBL-producers. In Korea, 44% of Klebsiella species produce ESBL. In Thailand, about 30% of three bacteria were ESBL-producers. In Taiwan, 9% of E. coli, 17% of Klebsiella spescies, and 25% of Enterobacter are ESBL-producers. * * * * * * FIG. 1. (A) Time-kill curves of Acinetobacter baumannii (AB1) incubated with meropenem (1MIC [256mg=L]), sulbactam (1MIC [128mg=L]), or colistin (1MIC [MIC1mg=L]) and varied combinations of these antibiotics. The lower limitation of viable count was set at 20 cfu=ml. (B) Time-kill curves of A. baumannii (AB134) when incubated with meropenem (1MIC [64mg=L]), sulbactam (1MIC [16mg=L]), or colistin (1MIC [1mg=L]) and varied combinations of these antibiotics. The lower limitation of viable count was set at 20 cfu=ml. * * Taking the focus to Asia-Pacific region. ESBL-producing bacteria are more common in China, Korea, and Thailand. In China, more than 40% of E. coli and more than 20% of Klebsiella and Enterobacter are ESBL-producers. In Korea, 44% of Klebsiella species produce ESBL. In Thailand, about 30% of three bacteria were ESBL-producers. In Taiwan, 9% of E. coli, 17% of Klebsiella spescies, and 25% of Enterobacter are ESB